BrainCells Inc.

A month after Otsuka Pharmaceutical Co. Ltd. agreed to buy cancer drug developer Astex Pharmaceuticals Inc. for $886 million, a top shareholder is challenging the deal. Sarissa Capital Managem

So long as its research goes as planned, PharmAkea's future is somewhat predictable now that the San Diego-based biopharmaceutical company has entered into a three-year, $35m funding and drug developm

Japan's Mitsubishi Tanabe Pharma (MTP) has confirmed that it will spin out and merge its blood plasma fractionation operations with those of the Japanese Red Cross Society later this year. The discuss

After a year operating the Korea-Seoul Life Science Fund – a collaboration between the Boston-based venture capital firm Oxford Biosciences, Korea’s Hanwha Venture Capital, the Seoul Metropolitan Gove